New National Institute for Health and Clinical Excellence guidelines change the discount rates for costs and effects from 6% and 1.5% respectively to 3.5% for both. This change gives a lower weight to future health effects and may worsen the cost effectiveness ratio, especially for preventive interventions. Differential discounting is more appropriate when non-monetary outcomes like QALYs are used NICE should return to a 1.5% discount rate for effects.
ASJC Scopus subject areas
- General Medicine